Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors

Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors

<i>Background and Objectives:</i> Hepatocellular carcinoma (HCC) is the leading cause of liver cancer worldwide and has a high mortality rate. Its incidence has increased due to metabolic-associated liver disease (MAFLD) epidemics. Liver transplantation and surgery remain the most resolu...

Full description

Bibliographic Details
Main Authors: Ludovico Abenavoli, Michele Montori, Gianluca Svegliati Baroni, Maria Eva Argenziano, Francesca Giorgi, Giuseppe Guido Maria Scarlata, Francesca Ponziani, Emidio Scarpellini
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Medicina
Subjects:
immunotherapy
checkpoint inhibitors
gut microbiota
fecal microbiota transplantation
Online Access:https://www.mdpi.com/1648-9144/59/8/1427

Similar Items

Similar Items